J&W Beijing Biotech Co., Ltd. was established in 2012 and is a wholly-owned subsidiary of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. The company specializes in the research, development, production, and sales of latex-enhanced immunoturbidimetric tests, chemiluminescence tests, intermediate products for coagulation tests, and their bioactive materials. The company boasts significant technical advantages, with over 80% of its workforce dedicated to R&D, and more than 80% of these personnel holding master's degrees or higher. J&W Beijing Biotech has established core-competitive technical platforms in latex-enhanced immunoturbidimetry, chemiluminescence, and coagulation testing. The company is capable of offering personalized product customization to meet the specific needs of different downstream partners. Committed to the principle of "Quality First", J&W Beijing Biotech delivers tests with optimal performance to its customers.

The company operates a GMP-certified production workshop spanning 2,000 square meters, with an annual output capacity of up to 40 tons. In terms of service, the company customizes its offerings to meet the specific requirements of its customers. By optimizing the ratio of bioactive materials to carriers, it maximizes the biological affinity of biomolecules to achieve optimal practical application outcomes. The company has established a strong position in the technical field and holds significant development potential in the upstream segment of the in vitro diagnostic (IVD) industry. Leveraging its inherent strengths, the company has been certified both as a Zhongguancun Life Science Park high-tech enterprise and a national high-tech enterprise.